Please wait a minute...
Reviews in Cardiovascular Medicine  2015, Vol. 16 Issue (1): 1-8     DOI: 10.3909/ricm0718
Review | Next articles
Inhaled Nitric Oxide in Acute Pulmonary Embolism: A Systematic Review
Tariq Bhat1, Adi Neuman2, Mohmad Tantary2, Hilal Bhat3, Daniel Glass2, William Mannino1, Muhammad Akhtar1, Alina Bhat2, Sumaya Teli4, James Lafferty1
1 Division of Cardiology, Staten Island University Hospital, Staten Island, NY
2 Department of Medicine, Staten Island University Hospital, Staten Island, NY
3 Department of Medicine, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
4 University of Sheffield School of Medicine, Sheffield, South Yorkshire, United Kingdom
Download:  PDF(680KB)  ( 201 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Acute pulmonary embolism (PE) is usually a complication secondary to migration of a deep venous clot or thrombi to lungs, but other significant etiologies include air, amniotic fluid, fat, and bone marrow. Regardless of the underlying etiology, little progress has been made in finding an effective pharmacologic intervention for this serious complication. Among the wide spectrum of PE, massive PE is associated with considerable morbidity and mortality, primarily due to severely elevated pulmonary vascular resistance leading to right ventricular failure, hypoxemia, and cardiogenic shock. We currently have limited therapeutic options at our disposal. Inhaled nitric oxide (iNO) has been proposed as a potential therapeutic agent in cases of acute PE in which hemodynamic compromise secondary to increased pulmonary vascular resistance is present, based on iNO's selective dilation of the pulmonary vasculature and antiplatelet activity. A systematic search of studies using the PubMed database was undertaken in order to assess the available literature. Although there are currently no published randomized controlled trials on the subject, except a recently publish phase I trial involving eight patients, several case reports and case series describe and document the use of iNO in acute PE. The majority of published reports have documented improvements in oxygenation and hemodynamic variables, often within minutes of administration of iNO. These reports, when taken together, raise the possibility that iNO may be a potential therapeutic agent in acute PE. However, based on the current literature, it is not possible to conclude definitively whether iNO is safe and effective. These case reports underscore the need for randomized controlled trials to establish the safety and efficacy of iNO in the treatment of massive acute PE. The purpose of this article is to review the current literature in the use of iNO in the setting of PE given how acute PE causes acute onset of pulmonary hypertension.
Key words:  Nitric oxide      Pulmonary embolism      Pulmonary hypertension     
Published:  30 March 2015     

Cite this article: 

Tariq Bhat, Adi Neuman, Mohmad Tantary, Hilal Bhat, Daniel Glass, William Mannino, Muhammad Akhtar, Alina Bhat, Sumaya Teli, James Lafferty. Inhaled Nitric Oxide in Acute Pulmonary Embolism: A Systematic Review. Reviews in Cardiovascular Medicine, 2015, 16(1): 1-8.

URL: 

https://rcm.imrpress.com/EN/10.3909/ricm0718     OR     https://rcm.imrpress.com/EN/Y2015/V16/I1/1

[1] Malik Bisserier, Natasha Pradhan, Lahouaria Hadri. Current and emerging therapeutic approaches to pulmonary hypertension[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 163-179.
[2] Faeq Husain-Syed, Horst-Walter Birk, Khodr Tello, Manuel J. Richter, Claudio Ronco, Peter A. McCullough, Tanja Schörmann, Fiorenza Ferrari, Gökhan Yücel, Babak Yazdani, Hans-Dieter Walmrath, Werner Seeger, Henning Gall, H. Ardeschir Ghofrani. Alterations in Doppler-derived renal venous stasis index during decompensation of right heart failure and fluid overload in a patient with pulmonary hypertension[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 263-266.
[3] Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[4] Jose P. Garcia, Adrian Santana, Diego Lugo Baruqui, Nicholas Suraci. The Cardiovascular effects of chocolate[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 123-127.
[5] Olayinka Afolabi-Brown, D. Lynn Morris, Vincent M. Figueredo. Global T-wave Inversion on Electrocardiogram: What Is the Differential?[J]. Reviews in Cardiovascular Medicine, 2014, 15(2): 131-141.
[6] Antonis N. Pavlidis, Manolis S. Kallistratos, Grigoris V. Karamasis, Athanasios S. Tsoukas, Ioannis P. Levantakis, Dimitrios Mauropoulos, Athanasios J. Manolis. Diagnosis and Risk Stratification in Acute Pulmonary Embolism: The Role of Echocardiography[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 56-65.
[7] Michael S. Lee, Ehtisham Mahmud. Percutaneous Revascularization for Left Main Coronary Artery Compression From Pulmonary Artery Enlargement Due to Pulmonary Hypertension[J]. Reviews in Cardiovascular Medicine, 2012, 13(1): 32-36.
[8] Kanwal Pratap Singh Raghav, Premraj Makkuni, Vincent M. Figueredo. A Review of Electrocardiography in Pulmonary Embolism: Recognizing Pulmonary Embolus Masquerading as ST-Elevation Myocardial Infarction[J]. Reviews in Cardiovascular Medicine, 2011, 12(3): 157-163.
[9] Navneet Lather, Mohamed Islam, Icilma V. Fergus. Symptomatic Metastatic Right Atrial Lymphoma in a Patient With AIDS Presenting With Pulmonary Embolization[J]. Reviews in Cardiovascular Medicine, 2008, 9(4): 275-279.
[10] Vishal Kapur, Christopher V. Chien, Justin E. Fuess, Ernst R. Schwarz. The Relationship Between Erectile Dysfunction and Cardiovascular Disease. Part II: The Role of PDE-5 Inhibition in Sexual Dysfunction and Cardiovascular Disease[J]. Reviews in Cardiovascular Medicine, 2008, 9(3): 187-195.
[11] Vishal Kapur, Ernst R. Schwarz. The Relationship Between Erectile Dysfunction and Cardiovascular Disease. Part I: Pathophysiology and Mechanisms[J]. Reviews in Cardiovascular Medicine, 2007, 8(4): 214-219.
[12] Jeffrey W. Olin. Pulmonary Embolism[J]. Reviews in Cardiovascular Medicine, 2002, 3(S2): 68-75.
[13] Stacey B. Gross, Norman E. Lepor. Anorexigen-Related Cardiopulmonary Toxicity[J]. Reviews in Cardiovascular Medicine, 2000, 1(2): 80-89.
No Suggested Reading articles found!